This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2001;285:1828-1829.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Orlando, Fla—Clopidogrel, an antiplatelet medication, was found when taken daily with aspirin to reduce risk of cardiovascular death, myocardial infarction (MI), and stroke by almost 20% in patients with acute coronary syndrome. Researchers said the drug, if given to everyone in the United States with acute coronary syndrome, could prevent between 50 000 and 100 000 new MIs, strokes, and deaths annually. The findings, by a research team headed by Salim Yusuf, MD, professor of medicine and director of the Division of Cardiology at McMaster University in Hamilton, Ontario, were presented at this year's American College of Cardiology Scientific Sessions.

Yusuf is principal investigator of the CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events) trial. CURE is a randomized, double-blind trial of 12562 patients in 28 counties that began recruitment in December 1998 and had the last day of follow-up in December 2000. Looking at its primary . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?
Kapetanakis et al.
Circulation 2006;113:1667-1674.
ABSTRACT | FULL TEXT  

Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery
Nurozler et al.
ICVTS 2005;4:546-549.
ABSTRACT | FULL TEXT  

Clopidogrel Hypersensitivity Syndrome With Rash, Fever, and Neutropenia
Doogue et al.
Mayo Clin Proc. 2005;80:1368-1370.
ABSTRACT  

In-Hospital Patients Exposed to Clopidogrel Before Coronary Artery Bypass Graft Surgery: A Word of Caution
Ascione et al.
Ann. Thorac. Surg. 2005;79:1210-1216.
ABSTRACT | FULL TEXT  

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Kapetanakis et al.
Eur Heart J 2005;26:576-583.
ABSTRACT | FULL TEXT  

Impact of clopidogrel in coronary artery bypass grafting
Englberger et al.
Eur. J. Cardiothorac. Surg. 2004;26:96-101.
ABSTRACT | FULL TEXT  

Coronary artery bypass graft surgery in patients with recent exposure to clopidogrel and aspirin therapy
Akowuah et al.
J Am Coll Cardiol 2003;41:1425-1426.
FULL TEXT  

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
Gum et al.
J Am Coll Cardiol 2003;41:961-965.
ABSTRACT | FULL TEXT  

The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting
Hongo et al.
J Am Coll Cardiol 2002;40:231-237.
ABSTRACT | FULL TEXT  

Refractory angina pectoris: Mechanism and therapeutic options
Kim et al.
J Am Coll Cardiol 2002;39:923-934.
ABSTRACT | FULL TEXT  

Atorvastatin for Acute Coronary Syndromes
Wierzbicki et al.
JAMA 2001;286:532-535.
FULL TEXT